Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Protocol: A systematic review and network meta-analysis of the effects of different doses of licensed statins on LDL cholesterol in humans in order to generate dose-response curves

STEVENS R. et al, (2020)

Protocol: A systematic review and network meta-analysis of the effects of different doses of licensed statins on LDL cholesterol in humans in order to generate dose-response curves

Monaghan G. et al, (2020)

Me-too pharmaceutical products: History, definitions, examples, and relevance to drug shortages and essential medicines lists.

Aronson JK. and Green AR., (2020), Br J Clin Pharmacol

Naltrexone–bupropion (Mysimba) in management of obesity: A systematic review and meta-analysis of unpublished clinical study reports

Onakpoya IJ. et al, (2020), British Journal of Clinical Pharmacology, 86, 646 - 667

The problem of look-alike, sound-alike (LASA) name errors: drivers and solutions.

Bryan R. et al, (2020), Br J Clin Pharmacol

Medical Devices: Definition, Classification, and Regulatory Implications

Aronson JK. et al, (2020), Drug Safety, 43, 83 - 93

Analysis of reports of unintended pregnancies associated with the combined use of non-enzyme-inducing antibiotics and hormonal contraceptives

Aronson JK. and Ferner RE., (2020), BMJ Evidence-Based Medicine

Forgotten Primodos story and the roles of general practitioners

Heneghan C. and Aronson J., (2020), BMJ Evidence-Based Medicine

The use of mechanistic reasoning in assessing coronavirus interventions

Aronson JK. et al, (2020), Journal of Evaluation in Clinical Practice

Sodium valproate: Who knew what and when? Cumulative meta-analysis gives extra insights

Heneghan C. and Aronson JK., (2019), BMJ Evidence-Based Medicine, 24, 127 - 129

Introducing the EBM Verdict: Research evidence relevant to clinical practice

Heneghan C. et al, (2019), BMJ Evidence-Based Medicine, 24, 85 - 86

Trends in kidney function testing in UK primary care since the introduction of the quality and outcomes framework: A retrospective cohort study using CPRD

Feakins B. et al, (2019), BMJ Open, 9

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: A systematic review of the world literature (BMC Med. (2016) 14 (10) DOI: 10.1186/s12916-016-0553-2)

Onakpoya IJ. et al, (2019), BMC Medicine, 17

Adverse events in people taking macrolide antibiotics versus placebo for any indication

Hansen MP. et al, (2019), Cochrane Database of Systematic Reviews, 2019

Extending anticoagulation treatment for unprovoked venous thromboembolism

Heneghan C. and Aronson J., (2019), BMJ Evidence-Based Medicine

Lorcaserin in obesity: Minimal benefits and ill-defined harms

Onakpoya IJ. and Aronson JK., (2019), BMJ Evidence-Based Medicine

Medical Devices: Classification and Analysis of Faults Leading to Harms

Ferner RE. and Aronson JK., (2019), Drug Safety

Susceptibility to adverse drug reactions

Ferner R. and Aronson J., (2019), British Journal of Clinical Pharmacology

The British Pharmacological Society's WDM Paton Memorial Lecture 2019: How doctors were informed about pharmaceutical products through advertising in the British Medical Journal from 1955/6 to 1985/6

Aronson JK. and Green AR., (2019), British Journal of Clinical Pharmacology, 85, 1901 - 1906

Withdrawn medicines included in the essential medicines lists of 136 countries

Charles O. et al, (2019), PLoS ONE, 14

Load More

1
2
3
4
5
6
7
...
»